產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-EEFSEC抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-EEFSEC抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-EEFSEC
Cat. Number:
Anti-EEFSEC抗體KL-14505R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
EEFSEC is a 596 amino acid protein that localizes to both the nucleus and the cytoplasm and belongs to the GTP-binding elongation factor family. Functioning as a translation factor, SELB binds GTP and GDP and is necessary for the incorporation of selenocysteine into target proteins. The gene encoding SELB maps toAnti-EEFSEC抗體 human chromosome 3, which houses over 1,100 genes, including a chemokine receptor (CKR) gene cluster and a variety of human cancer-related gene loci. Key tumor suppressing genes on chromosome 3 include those that encode the apoptosis mediator RASSF1, the cell migration regulator HYAL1 and the angiogenesis suppressor SEMA3B. Marfan Syndrome, porphyria, von Hippel-Lindau syndrome, osteogenesis imperfecta and Charcot-Marie-Tooth Disease are a few of the numerous genetic diseases associated with chromosome 3.
Also known as:
EFSEC; SELB_HUMAN；Anti-EEFSEC抗體 Elongation factor for selenoprotein translation; Elongation factor sec; Eukaryotic elongation factor, selenocysteine tRNA specific; SELB; Selenocysteine specific elongation factor.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human EEFSEC.
●
Predicted Molecular Weight: 65kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-EEFSEC抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must beAnti-EEFSEC抗體 determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must beAnti-EEFSEC抗體 determined by the end user.
kl578Mu01 Pim-1原癌基因(PIM1)多克隆抗體 Polyclonal Antibody to Pim-1 Oncogene (PIM1)
kl578Ra01 Pim-1原癌基因(PIM1)多克隆抗體 Polyclonal Antibody to Pim-1 Oncogene (PIM1)
kl305Hu01 甲狀腺結(jié)合球蛋白(TBG)多克隆抗體 Polyclonal Antibody to Thyroxine Binding Globulin (TBG)
kl305Mu01 甲狀腺結(jié)合球蛋白(TBG)多克隆抗體 Polyclonal Antibody to Thyroxine Binding Globulin (TBG)
kl305Ra01 甲狀腺結(jié)合球蛋白(TBG)多克隆抗體 Polyclonal Antibody to Thyroxine Binding Globulin (TBG)
kl702Hu01 硫氧化還原蛋白(Trx)多克隆抗體 Polyclonal Antibody to Thioredoxin (Trx)
kl702Mu01 硫氧化還原蛋白(Trx)多克隆抗體 Polyclonal Antibody to Thioredoxin (Trx)
kl702Ra01 硫氧化還原蛋白(Trx)多克隆抗體 Polyclonal Antibody to Thioredoxin (Trx)
kl084Mu01 瘦素(LEP)多克隆抗體 Polyclonal Antibody to Leptin (LEP)
kl084Ra01 瘦素(LEP)多克隆抗體 Polyclonal Antibody to Leptin (LEP)
kl036Hu01 轉(zhuǎn)鐵蛋白(TRF)多克隆抗體 Polyclonal Antibody to Transferrin (TRF)
kl036Mu01 轉(zhuǎn)鐵蛋白(TRF)多克隆抗體 Polyclonal Antibody to Transferrin (TRF)
kl036Ra01 轉(zhuǎn)鐵蛋白(TRF)多克隆抗體 Polyclonal Antibody to Transferrin (TRF)
kl123Hu01 轉(zhuǎn)化生長(zhǎng)因子α(TGFα)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Alpha (TGFa)
kl123Mu01 轉(zhuǎn)化生長(zhǎng)因子α(TGFα)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Alpha (TGFa)
kl123Ra01 轉(zhuǎn)化生長(zhǎng)因子α(TGFα)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Alpha (TGFa)
kl968Hu01 抑肽酶(AP)多克隆抗體 Polyclonal Antibody to Aprotinin (AP)
kl968Bo01 抑肽酶(AP)多克隆抗體 Polyclonal Antibody to Aprotinin (AP)
